Update on EXSCEL presented at the 2017 IDF Congress
On Wednesday December 6th, Professor Angelyn Bethel presented new data from the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). The invited talk, presented within the "Latest Cardiovascular Clinical Trials" symposium, shared a new meta-analysis of the four glucagon-like peptide-1 receptor agonist cardiovascular outcome trials conducted to date....
New ACE data presented at the 2017 IDF Congress
Some 8,000 delegates attended the 2017 IDF Congress in Abu Dhabi.
On Wednesday 6th December, Professor Rury Holman gave an invited talk in the "Latest Cardiovascular Clinical Trials" symposium....
DTU Welcomes New EFSD 2017 Mentee
Dr Ernesto Maddaloni
from the University Campus Bio-Medico, Rome, Italy is one of five Mentees selected for the new European Foundation for the Study of Diabetes (EFSD
) Future Leaders Mentorship Programme
, with Professor Rury Holman
as his Mentor.
During his inagaural visit to the Diabetes Trials Unit he gave an invited talk hosted by Prof. Holman on Wednesday 18th October 2017 in the OCDEM
Seminar Series entitled "The Bone-vascular Axis: Insights from Adults with Autoimmune Diabetes"....
DTU Director gives keynote lecture at GW-ICC in Beijing
Professor Rury Holman gave a lecture entitled "New Results from the ACE Trial" during the opening session of the 28th Great Wall of China International Congress of Cardiology (GW-ICC) in Beijing on Friday 13th October 2017. The meeting was attended by 20,285 delegates from 35 countries....
HOMA Calculator updated for Mac Excel 2016
The Macintosh version of the HOMA2 Calculator has been updated to version 2.2.3 to include support for Excel 2016. The HOMA API has also been updated to include support for R....
DTU Director gives plenary lecture at East Meets West Symposium in Hong Kong
Professor Rury Holman gave an invited plenary lecture in Hong Kong on Sunday 1st October 2017 at the 19th East Meets West Symposium focussing on Diabetes & Cardiovascular Risk Factors. His lecture, entitled "Updates on recent cardiovascular outcome studies in diabetes - from ACE to EXSCEL", reprised the key findings from the ACE trial and EXSCEL, first presented at the EASD in Lisbon on September 13th and 14th 2017 respectively.
UKPDS Risk Engine v2.01 for the Mac has been released
The Macintosh version of the UKPDS Risk Engine has been updated to enable it to run on MacOS X (Intel 32/64 bit) and with Microsoft Excel 2011/2016 or later.
DTU Director interviewed by Yang Lan during ACE trial China city tour
Professor Rury Holman presente...
EXSCEL primary results presented at the 53rd EASD annual meeting in Lisbon
Diabetes is a widespread and increasing problem currently affecting 30.3 million Americans, 4.5 million people living in the United Kingdom, and 422 million people worldwide. In 2015, an estimated 1.6 million deaths worldwide were directly caused by diabetes....
ACE trial primary results presented at the 53rd EASD annual meeting in Lisbon
People with coronary heart disease and impaired glucose tolerance are at increased risk of future cardiovascular events, and of developing type 2 diabetes. In 2006, 37.3% of Chinese adults hospitalised for coronary artery disease had impaired glucose regulation, a major risk factor for diabetes....
DTU Director gives CUHK Distinguished Lecture
Professor Rury Holman gave an invited lecture on Monday 8th May 2017 at the Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, in their Distinguished Lecture Series on Diabetes IV.
The lecture, entitled "The legacy of the United Kingdom Prospective Diabetes Study", provided the historical perspective to the 20-year trial and the 10-year post-trial monitoring period, and highlighted the major findings that have since been a major influence on clinical practice....